An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide ...

Saarvienin A, a newly identified glycopeptide antibiotic from Amycolatopsis, exhibits strong activity against multidrug-resistant bacteria, including vancomycin-resistant Enterococcus and MRSA.

Mice overcame a Lyme disease infection after being given an antibiotic that is often used for pneumonia, and its effect on their gut microbiomes was negligible ...

The bacterium belongs to the actinobacteria group, known for producing clinically important antibiotics such as vancomycin and rifamycin. Initial extracts from the strain demonstrated potent ...